The store will not work correctly when cookies are disabled.
1-(cyclopropylmethyl)-N-(2,4-dimethoxyphenyl)-1H-imidazo[4,5-c]pyridin-6-amine
ID: ALA4778552
PubChem CID: 162661977
Max Phase: Preclinical
Molecular Formula: C18H20N4O2
Molecular Weight: 324.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(Nc2cc3c(cn2)ncn3CC2CC2)c(OC)c1
Standard InChI: InChI=1S/C18H20N4O2/c1-23-13-5-6-14(17(7-13)24-2)21-18-8-16-15(9-19-18)20-11-22(16)10-12-3-4-12/h5-9,11-12H,3-4,10H2,1-2H3,(H,19,21)
Standard InChI Key: QIATUTKVKGZJDQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
6.4990 -2.5423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4978 -3.3619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2059 -3.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2041 -2.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9127 -2.5387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9130 -3.3574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6916 -3.6101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1726 -2.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6912 -2.2856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9444 -4.3872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7437 -4.5569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7898 -3.7699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0824 -3.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0876 -2.5437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3810 -2.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6720 -2.5427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6740 -3.3641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3811 -3.7695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9641 -2.1345 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9637 -1.3173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3487 -5.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5184 -4.3012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3841 -4.5867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6778 -4.9978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
21 11 1 0
22 21 1 0
11 22 1 0
18 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.38 | Molecular Weight (Monoisotopic): 324.1586 | AlogP: 3.60 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.20 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.47 | CX LogP: 2.77 | CX LogD: 2.76 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -1.12 |
References
1. Lewis A,Beresford A,Chambers MS,Clark G,Hartley DC,Hirst KL,Higashino M,Kawahadara S,Nakanishi M,Saito T,Imagawa A,Habashita H,Maidment S,Macleod AM,Owens AP,Rae A,Rouse C,Wishart G. (2020) Discovery of ONO-8590580: A novel, potent and selective GABA α negative allosteric modulator for the treatment of cognitive disorders., 30 (22): [PMID:32898695] [10.1016/j.bmcl.2020.127536] |